ALPMY - Astellas Pharma Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 526.32B
Enterprise Value 325.38B
Trailing P/E 14.95
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.20
Price/Book (mrq)2.17
Enterprise Value/Revenue 32.12
Enterprise Value/EBITDA 69.53

Financial Highlights

Fiscal Year
Fiscal Year Ends Mar 31, 2017
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin 15.01%
Operating Margin (ttm)17.31%
Management Effectiveness
Return on Assets (ttm)7.80%
Return on Equity (ttm)15.50%
Income Statement
Revenue (ttm)11.98B
Revenue Per Share (ttm)5.72
Quarterly Revenue Growth (yoy)-4.50%
Gross Profit (ttm)991.16B
EBITDA 2.66B
Net Income Avi to Common (ttm)1.8B
Diluted EPS (ttm)0.85
Quarterly Earnings Growth (yoy)-36.20%
Balance Sheet
Total Cash (mrq)2.9B
Total Cash Per Share (mrq)1.41
Total Debt (mrq)34.81M
Total Debt/Equity (mrq)0.28
Current Ratio (mrq)2.18
Book Value Per Share (mrq)5.84
Cash Flow Statement
Operating Cash Flow (ttm)2.56B
Levered Free Cash Flow (ttm)1.18B

Trading Information

Stock Price History
Beta 0.39
52-Week Change 3-8.17%
S&P500 52-Week Change 317.43%
52 Week High 314.50
52 Week Low 30.00
50-Day Moving Average 313.14
200-Day Moving Average 312.66
Share Statistics
Avg Vol (3 month) 380.03k
Avg Vol (10 day) 3111.4k
Shares Outstanding 52.04B
Float 1.99B
% Held by Insiders 10.00%
% Held by Institutions 10.17%
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 40.00%
Trailing Annual Dividend Rate 30.31
Trailing Annual Dividend Yield 32.43%
5 Year Average Dividend Yield 4N/A
Payout Ratio 416.23%
Dividend Date 3N/A
Ex-Dividend Date 4Sep 27, 2016
Last Split Factor (new per old) 2125/100
Last Split Date 3Apr 2, 2014